Back
Viridian Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
56
VRDN
Viridian Therapeutics
Last Price:
$17.05
Seasonality Move:
-12.23%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing slight selling pressure.
Viridian Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.07 | Buy |
20-day SMA: | 15.37 | Buy |
50-day SMA: | 14.31 | Buy |
200-day SMA: | 17.63 | Sell |
8-day EMA: | 10.72 | Buy |
20-day EMA: | 5.56 | Buy |
50-day EMA: | 2.49 | Buy |
200-day EMA: | 0.66 | Buy |
Viridian Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.76 | Buy |
Relative Strength Index (14 RSI): | 70.82 | Buy |
Chaikin Money Flow: | -70465 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.43 - 16.19) | Buy |
Bollinger Bands (100): | (12.93 - 15.79) | Buy |
Viridian Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viridian Therapeutics Stock
Is Viridian Therapeutics Stock a Buy?
-
Viridian Therapeutics share price is 17.04 while VRDN 8-day simple moving average is 16.07, which is a Buy signal.
-
The stock price of VRDN is 17.04 while Viridian Therapeutics 20-day SMA is 15.37, which makes it a Buy.
-
Viridian Therapeutics 50-day simple moving average is 14.31 while VRDN share price is 17.04, making it a Buy technically.
-
VRDN stock price is 17.04 and Viridian Therapeutics 200-day simple moving average is 17.63, creating a Sell signal.
VRDN Technical Analysis vs Fundamental Analysis
Buy
56
Viridian Therapeutics (VRDN)
is a Buy
Is Viridian Therapeutics a Buy or a Sell?
-
Viridian Therapeutics stock is rated a BuyThe current Viridian Therapeutics [VRDN] share price is $17.04. The Score for VRDN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Viridian Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
17.04
Share Volume:
477.6K
Viridian Therapeutics 52-Week Range
52-Week High:
27.20
52-Week Low:
9.90
Buy
56
Viridian Therapeutics (VRDN)
is a Buy
Viridian Therapeutics Share Price Forecast
-
What is the Viridian Therapeutics stock price today?The Viridian Therapeutics stock price is 17.04 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics is not overvalued.
Is Viridian Therapeutics Stock a Buy?
-
Viridian Therapeutics share price is 17.04 while VRDN 8-day exponential moving average is 10.72, which is a Buy signal.
-
The stock price of VRDN is 17.04 while Viridian Therapeutics 20-day EMA is 5.56, which makes it a Buy.
-
Viridian Therapeutics 50-day exponential moving average is 2.49 while VRDN share price is 17.04, making it a Buy technically.
-
VRDN stock price is 17.04 and Viridian Therapeutics 200-day simple moving average is 0.66, creating a Buy signal.
Fundamental Analysis of Viridian Therapeutics
Is Viridian Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.02 per share, and an increase next year of $0.31 per share.
Technical Analysis of Viridian Therapeutics
Should I short Viridian Therapeutics stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is 3.76, suggesting Viridian Therapeutics is a Buy
-
Viridian Therapeutics Relative Strength Index (RSI) is 70.82, which suggest Viridian Therapeutics is overbought
-
The Bollinger Bands (25) for Viridian Therapeutics is (14.43 - 16.19), which suggest Viridian Therapeutics is a Buy
-
The Bollinger Bands (100) for Viridian Therapeutics is (12.93 - 15.79), which suggest Viridian Therapeutics is a Buy
* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.